enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. EU investigates Ozempic, weight-loss drug Saxenda after ... - AOL

   www.aol.com/news/eu-probes-novo-nordisk-drugs...

   (Reuters) -The European Medicines Agency (EMA) is investigating Novo Nordisk's diabetes drug Ozempic and weight-loss treatment Saxenda after Iceland's health regulator flagged three cases of ...

3. EU regulator to review reports of suicidal thoughts and ... - AOL

   www.aol.com/news/eu-regulator-review-reports...

   The agency began its review into the class of weight loss and diabetes drugs, known as GLP-1 receptor agonists, last July after Iceland's health regulator flagged three cases of patients thinking ...

4. Most people quit Wegovy, Saxenda before they see weight ... - AOL

   www.aol.com/lifestyle/most-people-quit-wegovy...

   Researchers report that more than half of people on weight loss drugs Wegovy and Saxenda stop taking them at 12 weeks or earlier. They said that 30% of people on the drugs stop using them within ...

5. Semaglutide - Wikipedia

   en.wikipedia.org/wiki/Semaglutide

   A 2022 review of anti-obesity treatments found that semaglutide as well as tirzepatide ... [100] Wegovy, Saxenda, and similar drugs. [101] ...

6. Liraglutide - Wikipedia

   en.wikipedia.org/wiki/Liraglutide

   Liraglutide, sold under the brand name Victoza among others, is an anti-diabetic medication used to treat type 2 diabetes, and chronic obesity. [6] [7] It is a second-line therapy for diabetes following first-line therapy with metformin.

7. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   Orlistat (Xenical), the most commonly used medication to treat obesity and sibutramine (Meridia), a medication that was withdrawn due to cardiovascular side effects. Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat.

8. Drugs You Don't Need For Disorders You Don't Have - The ...

   highline.huffingtonpost.com/articles/en/sleep...

   In a January 2016 report, the nonprofit Institute for Safe Medication Practices analyzed more than 1,000 consumer complaints that the FDA had received about Belsomra between February and July 2015—a number the institute described as “substantial.” A large number came from patients who complained that the drug was ineffective.

9. 6 Potential Long-Term Effects of Ozempic - AOL

   www.aol.com/6-potential-long-term-effects...

   2. Acute Kidney Injury. Some reports in a review supported by Novo Nordisk suggested that semaglutide may decrease the risk of kidney disease over the long term. But there were also a few reports ...